FMoc-Phe(4-Boc2-guanidino)-OH

Suppliers

Names

[ CAS No. ]:
187283-25-6

[ Name ]:
FMoc-Phe(4-Boc2-guanidino)-OH

[Synonym ]:
Fmoc-4-(N,N'-di-Boc-guanidino)-L-phenylalanine
Fmoc-4-guanidino-phenylalanine(N,N'-di-Boc)-OH
FMoc-Phe(4-Boc2-guanidino)-OH
Fmoc-p-(N,N'-Boc-guanidino)Phe
MFCD02092975
FMOC-PHE(4-GUANIDINO-BOC2)-OH
4-[[Bis[[(1,1-Dimethylethoxy)Carbonyl]Amino]Methylene]Amino]-N-[(9H-Fluoren-9-Ylmethoxy)Carbonyl]-L-Phenylalanine

Chemical & Physical Properties

[ Density]:
1.26g/cm3

[ Molecular Formula ]:
C35H40N4O8

[ Molecular Weight ]:
644.71400

[ Exact Mass ]:
644.28500

[ PSA ]:
164.65000

[ LogP ]:
7.43060

[ Index of Refraction ]:
1.597

[ Storage condition ]:
2-8°C

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3

Synthetic Route

Precursor & DownStream

Precursor

  • Fmoc-Osu
  • H-Phe(4-NH2)-OH.HCl

DownStream

Articles

Human tissue kallikrein S1 subsite recognition of non-natural basic amino acids.

Biochemistry 40 , 5226, (2001)

We explored the unique substrate specificity of the primary S(1) subsite of human urinary kallikrein (hK1), which accepts both Phe and Arg, using internally quenched fluorescent peptides Abz-F-X-S-R-Q...


More Articles


Related Compounds

  • Fmoc-Phe(4-vinyl)-OH
  • Fmoc-Phe(4-tBu)-OH
  • Fmoc-Phe(4-CN)-OH
  • Fmoc-Phe(4-NH2)-OH
  • Fmoc-Phe(4-N3)-OH
  • Fmoc-Phe(4-NHBoc)-OH
  • 2-{4-[2-Methyl-6-(morpholin-4-yl)pyrimidin-4-yl]piperazin-1-yl}-4,5,6,7-tetrahydro-1,3-benzothiazole
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • rac-2-cyclopropyl-2-{[(1R,5R,6S)-6-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)bicyclo[3.2.0]heptan-3-yl]formamido}acetic acid
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • 3-[9-[(3-Bromophenyl)methyl]-6-(3-carbamimidoylphenyl)carbazol-3-yl]benzenecarboximidamide
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde